Role at PCR

As CEO of Prostate Cancer Research, I lead the organisations strategic direction, driving its mission to improve prostate cancer diagnosis and treatment. My role involves engaging with funders, policy influencers, and partners to deliver impactful research and advocacy.

Bio

I have over 15 years of leadership of nonprofit organisations and have raised over £300 million as CEO or Chair. In particular, I have extensive experience in patient-centred research, cross-sector collaboration, and operational scaling.

I hold Chair and Vice Chair roles in organisations addressing health inequities in the UK and globally.

What can I talk about

• Overall prostate cancer landscape, including diagnosis, treatment, and emerging technologies
• Health policy and the importance of early diagnosis
• Impactful research approaches, from applied to translational research
• Addressing health inequities and improving trust in underserved communities

Role at PCR

I’m responsible for our exciting portfolio of medical and social science research. I also lead our communications work, using research-driven campaigns to drive change for people affected by prostate cancer.

I joined PCR in 2018 and am proud that in that time we have scaled up our research more than five times over, and created initiatives including greater support for early career researchers, making grant selection more equitable, and creating and launching targeted funding calls to meet key areas of patient need, such as our award winning Racial Disparities grant programme.

Bio

I have a PhD in medical oncology from the Royal College of Surgeons in Ireland. My PhD included getting a new drug for treatment-resistant breast cancer to clinical trial.

I also have a background in science communication, and in advocacy. This includes being co-recipient of a national award to investigate and report on health disparities in Guatemala as a journalist, and my own medical research being the spotlight of a national publicity campaign.

I have held leadership and advisory roles across charities and think tanks addressing health, gender and economic inequalities.

What can I talk about

• Overall prostate cancer landscape, including emerging trends and technologies
• Prostate cancer research
• Health inequalities, including the role of research in closing the gap
• Prostate cancer within the wider public health landscape
• Workforce issues in STEM

Role at PCR:

I lead PCR’s Patient Projects team, developing innovative, patient-focused initiatives like the infopool and Prostate Progress to support and educate those affected by prostate cancer.

I also direct our Influencing work, building a broad coalition—including politicians, policymakers, healthcare professionals, industry leaders, and patients—to push for urgent improvements in prostate cancer detection, treatment, and care.

Bio:

With over a decade of global experience in political campaigns, including multiple Obama campaigns, and successful project development and delivery in the Middle East and South Asia, I specialise in mobilising communities, driving engagement, and providing the effective support needed to deliver meaningful, lasting change.

What can I talk about:

• The prostate cancer landscape: policy, screening, and diagnostic advancements.
• Patient experience and health inequalities in prostate cancer care.
• The economic and public health case for investment in prostate cancer research.
• Campaigning, coalition-building, and influencing policy change.

Role at PCR:
As Translational Research Director at PCR, I lead initiatives that bridge the gap between scientific discovery and real-world patient impact. My work focuses on accelerating the development and adoption of innovative prostate cancer treatments.

Bio:

I have a BSc in Genetics and a PhD from Cambridge University. A post-doctoral researcher by background, I have also worked for the DHSC, focusing on genetics, genomics and gene therapy, and I have also served as Associated Director of the Centre for Clinical Practice at NICE. I have spent the past 17 years in the third sector in CEO, Director and non-exec positions, working to ensure that scientific advancements and policy initiatives translate into meaningful benefits for patients.

What can I talk about:

• Prostate cancer research, innovation, and the translational pipeline
• The role of real-world data in shaping healthcare and clinical trials
• Patient engagement in medical research and treatment development
• Philanthropy and investment in healthcare innovation